ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

NTLA Intellia Therapeutics Inc

27.51
0.49 (1.81%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,053,673
Bid Price 27.20
Ask Price 28.00
News -
Day High 28.23

Low
22.665

52 Week Range

High
47.48

Day Low 26.61
Company Name Stock Ticker Symbol Market Type
Intellia Therapeutics Inc NTLA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.49 1.81% 27.51 20:00:00
Open Price Low Price High Price Close Price Prev Close
26.98 26.61 28.23 27.51 27.02
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
14,557 1,053,673 $ 27.25 $ 28,707,337 - 22.665 - 47.48
Last Trade Time Type Quantity Stock Price Currency
19:34:27 72 $ 28.00 USD

Intellia Therapeutics (NTLA) Options Flow Summary

Overall Flow

Bullish

Net Premium

296k

Calls / Puts

800.00%

Buys / Sells

350.00%

OTM / ITM

28.57%

Sweeps Ratio

0.00%

Intellia Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.64B 96.11M - 36.28M -481.19M -5.01 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Intellia Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NTLA Message Board. Create One! See More Posts on NTLA Message Board See More Message Board Posts

Historical NTLA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week28.3728.5426.0626.991,012,895-0.86-3.03%
1 Month33.8034.8726.0629.331,496,980-6.29-18.61%
3 Months29.3534.8723.6327.961,593,768-1.84-6.27%
6 Months32.0034.8722.66528.321,523,385-4.49-14.03%
1 Year36.9247.4822.66532.691,209,464-9.41-25.49%
3 Years63.40202.7322.66567.251,232,661-35.89-56.61%
5 Years16.26202.739.1855.871,088,90711.2569.19%

Intellia Therapeutics Description

Intellia Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Your Recent History

Delayed Upgrade Clock